CCC
BNTX icon

Chesapeake Capital Corp’s BioNTech BNTX Stock Holding History

Chesapeake Capital Corp’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$426K Hold
3,739
– – 0.43% 102
2024
Q3 		$442K Buy
+3,739
New +$344K 0.4% 118

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Chesapeake Capital Corp's BNTX Position: Q4 2024 in Review

Chesapeake Capital Corp held its BioNTech (BNTX) position steady in Q4 2024 at 3,739 shares worth $426K. The position accounts for 0.43% of the portfolio, ranked #102.

Chesapeake Capital Corp first reported a position in BNTX in Q3 2024 and has held it in 2 quarters since. The position peaked at $442K in Q3 2024. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Chesapeake Capital Corp held 3,739 shares of BioNTech worth $426K as of Q4 2024.
  • Chesapeake Capital Corp left its BioNTech share count unchanged in Q4 2024.
  • BioNTech made up 0.43% of Chesapeake Capital Corp's portfolio in Q4 2024, its #102 holding.
  • Chesapeake Capital Corp first reported a position in BioNTech in Q3 2024 and has held it in 2 quarters since.
  • Chesapeake Capital Corp's BioNTech position peaked at $442K in Q3 2024.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Chesapeake Capital Corp's 13F filing for Q4 2024, filed 11 Feb 2025.